JP2020504122A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020504122A5 JP2020504122A5 JP2019535810A JP2019535810A JP2020504122A5 JP 2020504122 A5 JP2020504122 A5 JP 2020504122A5 JP 2019535810 A JP2019535810 A JP 2019535810A JP 2019535810 A JP2019535810 A JP 2019535810A JP 2020504122 A5 JP2020504122 A5 JP 2020504122A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- optionally substituted
- aryl
- heteroaryl
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 Cc(cc1)ccc1N/C1=C\C*/C(/CC(CCCC2)CCN2c2cc(OC)ccc2)=N/C(/N)=N1 Chemical compound Cc(cc1)ccc1N/C1=C\C*/C(/CC(CCCC2)CCN2c2cc(OC)ccc2)=N/C(/N)=N1 0.000 description 5
- AQJLZOXYUHCQCV-UHFFFAOYSA-N CC(CCCc1ccc(C)cc1)CCc1nc(N)nc(Nc2ccccc2C)n1 Chemical compound CC(CCCc1ccc(C)cc1)CCc1nc(N)nc(Nc2ccccc2C)n1 AQJLZOXYUHCQCV-UHFFFAOYSA-N 0.000 description 2
- JUCGCZDYNSFCKZ-UHFFFAOYSA-N Cc(cc1)ccc1Nc1nc(CC2CCOCCCC2)nc(N)n1 Chemical compound Cc(cc1)ccc1Nc1nc(CC2CCOCCCC2)nc(N)n1 JUCGCZDYNSFCKZ-UHFFFAOYSA-N 0.000 description 1
- QYJQPVDGBPGYEX-UHFFFAOYSA-N Cc(cc1)ccc1Nc1nc(CN(CC2)c3c2cccc3)nc(N)n1 Chemical compound Cc(cc1)ccc1Nc1nc(CN(CC2)c3c2cccc3)nc(N)n1 QYJQPVDGBPGYEX-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16382672.0 | 2016-12-29 | ||
| EP16382672 | 2016-12-29 | ||
| PCT/IB2017/058477 WO2018122775A1 (en) | 2016-12-29 | 2017-12-28 | Heteroaryl compounds and their use |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020504122A JP2020504122A (ja) | 2020-02-06 |
| JP2020504122A5 true JP2020504122A5 (enExample) | 2021-02-12 |
| JP7171057B2 JP7171057B2 (ja) | 2022-11-15 |
Family
ID=57708486
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019535810A Active JP7171057B2 (ja) | 2016-12-29 | 2017-12-28 | ヘテロアリール化合物およびその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US11174242B2 (enExample) |
| EP (1) | EP3562811B1 (enExample) |
| JP (1) | JP7171057B2 (enExample) |
| CN (1) | CN110325516A (enExample) |
| AU (1) | AU2017388466B2 (enExample) |
| BR (1) | BR112019013571A2 (enExample) |
| CA (1) | CA3048357A1 (enExample) |
| IL (1) | IL267626B2 (enExample) |
| WO (1) | WO2018122775A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112019013571A2 (pt) | 2016-12-29 | 2020-01-07 | Minoryx Therapeutics S.L. | Compostos heteroarila e seu uso |
| WO2020104578A2 (en) * | 2018-11-21 | 2020-05-28 | University Of Copenhagen | Modulators of free fatty acid receptor 1 and their use for treatment of diseases |
| AU2020394602B2 (en) * | 2019-11-25 | 2026-05-21 | Gt Gain Therapeutics Sa | Heteroaryl compounds and therapeutic uses thereof in conditions associated with the alteration of the activity of beta-glucocerebrosidase |
| WO2021183596A1 (en) * | 2020-03-10 | 2021-09-16 | University Of Cincinnati | Materials and methods for the treatment of gaucher disease |
| CN117659017B (zh) * | 2022-08-25 | 2026-05-15 | 北京华益健康药物研究中心 | Trpml1/2调节剂化合物、药物组合物及其制备方法和应用 |
| WO2024206067A2 (en) * | 2023-03-24 | 2024-10-03 | Purdue Research Foundation | Symmetric aminoindole-linked triazine for a dual effect on alpha-synuclein and tau isoform 2n4r fibrillization |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HK1045157A1 (zh) | 1999-01-22 | 2002-11-15 | 依兰制药公司 | 抑制vla-4介导的白细胞粘着的化合物 |
| AU3950802A (en) | 2000-12-07 | 2002-06-18 | Cv Therapeutics Inc | Abca-1 elevating compounds |
| EP1363638A4 (en) * | 2001-01-31 | 2010-01-06 | Lundbeck & Co As H | USE OF GAL3 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF DEPRESSION AND / OR ANXIETIES AND USEFUL CONNECTIONS FOR SUCH PROCEDURES |
| US20030078271A1 (en) | 2001-01-31 | 2003-04-24 | Blackburn Thomas P. | Use of GAL3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods |
| MXPA04007191A (es) | 2002-01-23 | 2005-03-31 | Bayer Pharmaceuticals Corp | Derivados de pirimidina como inhibidores de rho-quinasa. |
| ES2273047T3 (es) | 2002-10-28 | 2007-05-01 | Bayer Healthcare Ag | Fenilaminopirimidinas sustituidas con heteroariloxi como inhibidores de rho-cinasa. |
| CN1199946C (zh) | 2002-10-29 | 2005-05-04 | 无锡杰西医药科技有限公司 | 一种特异性吲哚类化合物及制备方法与其在治疗和预防癌症等疾病中的应用 |
| WO2006110763A1 (en) | 2005-04-08 | 2006-10-19 | Bayer Pharmaceuticals Corporation | Pyrimidine derivatives and their use for the treatment of cancer |
| US20090306038A1 (en) | 2005-09-13 | 2009-12-10 | Carceller Gonzalez Elena | 2-Aminopyrimidine derivatives as modulators of the histamine H4 receptor activity |
| JP5337405B2 (ja) | 2007-09-17 | 2013-11-06 | ザ・ホスピタル・フォー・シック・チルドレン | ゴーシェ病の治療方法 |
| US8138356B2 (en) | 2007-10-16 | 2012-03-20 | Angiogeney, Inc. | Chemical inhibitors of inhibitors of differentiation |
| AU2008345225A1 (en) * | 2007-12-21 | 2009-07-09 | University Of Rochester | Method for altering the lifespan of eukaryotic organisms |
| US20130023498A1 (en) | 2008-02-20 | 2013-01-24 | The Wistar Institute and North Carolina State University | MicroRNA Modulators and Method for Identifying and Using the Same |
| CN104530052A (zh) | 2008-06-10 | 2015-04-22 | 普莱希科公司 | 用于激酶调节的5h-吡咯[2,3-b]吡嗪衍生物和其适应症 |
| WO2011049737A1 (en) | 2009-10-19 | 2011-04-28 | Amicus Therapeutics, Inc. | Novel compositions for preventing and/or treating lysosomal storage disorders |
| WO2012035055A1 (en) | 2010-09-17 | 2012-03-22 | Glaxo Group Limited | Novel compounds |
| LT2685986T (lt) | 2011-03-18 | 2020-03-10 | Genzyme Corporation | Gliukozilceramido sintazės slopiklis |
| AU2012272815B2 (en) | 2011-06-22 | 2017-09-07 | The General Hospital Corporation | Treatment of proteinopathies |
| US8961959B2 (en) | 2011-10-17 | 2015-02-24 | The Regents Of The University Of Michigan | Glucosylceramide synthase inhibitors and therapeutic methods using the same |
| MX354127B (es) | 2012-03-27 | 2018-02-14 | Amicus Therapeutics Inc | Compuestos novedosos para prevenir y/o tratar tesaurismosis lisosomicas y/o trastornos degenerativos del sistema nervioso central. |
| IN2015DN03761A (enExample) | 2012-10-24 | 2015-10-02 | Glucox Biotech Ab | |
| EP3027590A1 (en) | 2013-07-31 | 2016-06-08 | Minoryx Therapeutics S.L. | Di(hetero)arylamides and sulfonamides, methods for their preparation and therapeutic uses thereof |
| US10738026B2 (en) | 2014-02-12 | 2020-08-11 | Purdue Pharma L.P. | Isoquinoline derivatives and use thereof |
| EP3215511B1 (en) | 2014-11-06 | 2024-04-17 | Bial-R&D Investments, S.A. | Substituted pyrazolo(1,5-a)pyrimidines and their use in the treatment of medical disorders |
| WO2016120808A1 (en) | 2015-01-28 | 2016-08-04 | Minoryx Therapeutics S.L. | Heteroarylaminoisoquinolines, methods for their preparation and therapeutic uses thereof |
| EP3258937A4 (en) | 2015-02-16 | 2018-10-31 | Glucox Biotech AB | N2-(3,4-dimethylphenyl)-6-((4-(p-tolyl)piperazin-1-yl)methyl)-1,3,5-triazine-2,4-diamine |
| US20180092923A1 (en) | 2015-04-15 | 2018-04-05 | Biomarin Pharmaceutical Inc. | Methods for treating lysosomal storage disorders |
| US10308656B2 (en) | 2015-08-18 | 2019-06-04 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Small molecule inhibitors of Ku70/80 and uses thereof |
| CN105412114A (zh) | 2015-12-11 | 2016-03-23 | 卢璐娇 | 6-{[4-(2-氟苯基)1-哌嗪基]甲基}-n-(萘基)-1,3,5-三嗪-2,4-二胺在制备血管生成抑制剂中的应用 |
| BR112019013571A2 (pt) | 2016-12-29 | 2020-01-07 | Minoryx Therapeutics S.L. | Compostos heteroarila e seu uso |
-
2017
- 2017-12-28 BR BR112019013571-5A patent/BR112019013571A2/pt not_active IP Right Cessation
- 2017-12-28 CA CA3048357A patent/CA3048357A1/en active Pending
- 2017-12-28 AU AU2017388466A patent/AU2017388466B2/en not_active Ceased
- 2017-12-28 CN CN201780086577.0A patent/CN110325516A/zh active Pending
- 2017-12-28 US US16/474,461 patent/US11174242B2/en active Active
- 2017-12-28 WO PCT/IB2017/058477 patent/WO2018122775A1/en not_active Ceased
- 2017-12-28 JP JP2019535810A patent/JP7171057B2/ja active Active
- 2017-12-28 EP EP17829719.8A patent/EP3562811B1/en active Active
-
2019
- 2019-06-25 IL IL267626A patent/IL267626B2/en unknown
-
2021
- 2021-10-06 US US17/495,542 patent/US11739072B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2016299485B2 (en) | 1,3,4-oxadiazole amide derivative compound as histone deacetylase 6 inhibitor, and pharmaceutical composition containing same | |
| JP2020519606A5 (enExample) | ||
| JP2020504711A5 (enExample) | ||
| JP2016534134A5 (enExample) | ||
| JP2020503297A5 (enExample) | ||
| HUP0401876A2 (hu) | Béta2 adrenerg receptor agonista hatású aril-anilin-származékok, valamint ezeket tartalmazó gyógyászati készítmények és alkalmazásuk | |
| JPH11193281A (ja) | アデノシンａ３受容体拮抗剤およびチアゾール化合物 | |
| NO900991D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2-(l-piperazinyl)-4-fenylcycloalkanopyridin-derivater | |
| JP2008513515A5 (enExample) | ||
| JP2005513026A5 (enExample) | ||
| JP2020533352A5 (enExample) | ||
| BR112012032813A2 (pt) | composto, composição farmacêutica, e, método para prevenir, tratar ou melhorar uma doença ou condição. | |
| RU2017145930A (ru) | МОДУЛЯТОРЫ ROR ГАММА (RORγ) | |
| BR112023025599A2 (pt) | Ativadores de dimetoxifenilalquilamina de receptores de serotonina. | |
| JP2013542267A5 (enExample) | ||
| CN111601797A (zh) | 苯并哌啶或杂芳基并哌啶类衍生物、其制备方法及其在医药上的应用 | |
| JPWO2023195529A5 (enExample) | ||
| CA2730471A1 (en) | Piperazine derivatives used as cav2.2 calcium channel modulators | |
| RU2006138426A (ru) | Производные тиазолопиридина, содержащие их фармацевтические композиции и способы лечения состояний, опосредованных глюкокиназой | |
| CA2618511A1 (en) | Novel benzothiazolone derivatives | |
| CA2405408A1 (en) | Pyrazole compounds | |
| JP2020111571A5 (enExample) | ||
| HRP20041087B1 (hr) | Derivati n-acilaminobenzena kao selektivni inhibitori monoamin oksidaze b | |
| US20020049205A1 (en) | Pyrazole antimicrobial agents | |
| JP2004521913A5 (enExample) |